A biocatalytic approach to synthesizing optically active orthogonally protected trans-cyclopentane-1,2-diamine derivatives

Journal of Organic Chemistry

Volumn 72, Issue 4, 2007, Pages 1309-1314

  González Sabín, Javier ^a   Gotor, Vicente ^a   Rebolledo, Francisca ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYL SUBSTITUENTS; ENZYMATIC REACTION; RACEMIC DIAMINES;

ACYLATION; ALCOHOLS; CATALYSIS; SOLUTIONS; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

AMINES;

AMINOALCOHOL; CYCLOPENTANE 1,2 DIAMINE DERIVATIVE; CYCLOPENTANE DERIVATIVE; LIPASE B; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ANTARCTICA; CATALYSIS; CHEMICAL REACTION; DERIVATIZATION; OPTICAL ROTATION; ORGANIC CHEMISTRY; RACEMIC MIXTURE; STEREOCHEMISTRY; STEREOSPECIFICITY; SYNTHESIS;

CATALYSIS; CYCLOPENTANES; LIPASE; MOLECULAR STRUCTURE;

EID: 33846943712     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo062205h     Document Type: Article

References (60)

1. (a) Eisenberg, M. A. In Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology; Neidhardt, F. C., Ed.; American Society for Microbiology: Washington, DC, 1987; Vol. 1, pp 544-550.
2. (b) Marquet, A. Pure Appl. Chem. 1993, 65, 1249-1252.
3. Gardiner, R. A.; Rinehart, K. L., Jr.; Snyder, J. J.; Broquist, H. P. J. Am. Chem. Soc. 1968, 90, 5639-5640.
4. Kulanthaivel, P.; Hallock, Y. F.; Boros, C.; Hamilton, S. M.; Janzen, W. P.; Ballas, L. M.; Loomis, C. R.; Jiang, J. P.; Katz, B.; Steiner, J. R.; Clardy, J. J. Am. Chem. Soc. 1993, 115, 6452-6453.
5. (a) Brunner, H.; Hankofer, P.; Holzinger, U.; Treittinger, B.; Schönenberger, H. Eur. J. Med. Chem. 1990, 25, 35-44.
6. (b) Brunner, H.; Hankofer, P.; Holzinger, U.; Treittinger, B. Chem. Ber. 1990, 123, 1029-1038.
7. (c) Gust, R.; Burgemeister, T.; Mannschreck, A.; Schönenberger, H. J. Med. Chem. 1990, 33, 2535-2544.
8. (d) Kelland, L. R.; Abel, G.; McKeage, M. J.; Jones, M.; Goddard, P. M.; Valenti, M.; Murrer, B. A.; Harrap, K. R. Cancer Res. 1993, 5, 2581-2586.
9. (e) Kim, D.-K.; Kim, Y.-W.; Kim, H.-T.; Kim, K. H. Bioorg. Med. Chem. Lett. 1996, 6, 643-646.
10. (f) Khokhar, A. R.; Al-Baker, S.; Shamsuddin, S.; Siddik, Z. H. J. Med. Chem. 1997, 40, 112-116.
11. (g) Reedijk, J. Chem. Commun. 1996, 801-806.
12. (a) Szmuszkovicz, J.; Von Voigtlander, P. F. J. Med. Chem. 1982, 25, 1125-1126.
13. (b) Szmuszkovicz, J. Eur. Pat. Appl. EP 126612, 1984; Chem. Abstr. 1985, 102, 184969b.
14. (c) Clark, C. R.; Halfpenny, P. R.; Hill, R. G.; Horwell, D. C.; Hughes, J.; Jarvis, T. C.; Rees, D. C.; Schofield, D. J. Med. Chem. 1988, 31, 831-836.
15. (d) Costello, G. F.; James, R.; Shaw, J. S.; Slater, A. M.; Stutchbury, N. C. J. J. Med. Chem. 1991, 34, 181-189.
16. (e) Barlow, J. J.; Blackburn, T. P.; Costello, G. F.; James, R.; Le Count, D. J.; Main, B. G.; Pearce, R. J.; Russell, K.; Shaw, J. S. J. Med. Chem. 1991, 34, 3149-3158.
17. Lucet, D.; Le Gall, T.; Mioskowski, C. Angew. Chem., Int. Ed. 1998, 37, 2580-2627.
18. For an excellent review, see: (a) Bennani, Y. L.; Hanessian, S. Chem. Rev. 1997, 97, 3161-3196.
19. For some recent examples of the utility of trans-cyclohexane-1,2- diamine derivatives in asymmetric catalysis, see: (b) Huang, H.; Jacobsen, E. N. J. Am. Chem. Soc. 2006, 128, 7170-7171.
20. (c) Fuerst, D. E.; Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 8964-8965.
21. (d) Evans, D. A.; Seidel, D. J. Am. Chem. Soc. 2005, 127, 9958-9959.
22. (e) Aoyama, H.; Tokunaga, M.; Kiyosu, J.; Iwasawa, T.; Obora, Y.; Tsuji, Y. J. Am. Chem. Soc. 2005, 127, 10474-10475.
23. For some examples of macrocyclic receptors containing the trans-cyclohexane-1,2-diamine unit, see: (f) Pan, Z.; Still, W. C. Tetrahedron Lett. 1996, 37, 8699-8702.
24. (g) Alfonso, I.; Rebolledo, F.; Gotor, V. Chem. - Eur. J. 2000, 6, 3331-3338.
25. (h) Alfonso, I.; Dietrich, B.; Rebolledo, F.; Gotor, V.; Lehn, J.-M. Helv. Chim. Acta. 2001, 84, 280-295.
26. (i) Lee, K. H.; Lee, D. H.; Hwang, S.; Lee, O. S.; Chung, D. S.; Hong, J.-I. Org. Lett. 2003, 5, 1431-1433.
27. (a) García, C.; Walsh, P. J. Org. Lett. 2003, 5, 3641-3644.
28. (b) Li, H.; Walsh, P. J. J. Am. Chem. Soc. 2004, 126, 6538-6539.
29. Palmer, M. J.; Wills, M. Tetrahedron: Asymmetry 1999, 10, 2045-2061.
30. McGarrigle, E. M.; Gilheany, D. G. Chem. Rev. 2005, 105, 1563-1602.
31. Optically active trans-cyclopentane-1,2-diamine was prepared for the first time by applying the classical recrystallization with tartaric acid. However, high enantiomeric excesses were obtained only after several recrystallization cycles, which led to a low overall yield: Toftlund, H.; Pedersen, E. Acta Chem. Scand. 1972, 26, 4019-4030.
32. (a) Ongeri, S.; Aitken, D. J.; Husson, H.-P. Synth. Commun. 2000, 30, 2593-2597.
33. (b) Luna, A.; Alfonso, I.; Gotor, V. Org. Lett. 2002, 4, 3627-3629.
34. (c) de Parrodi, C. A.; Walsh, P. J. Synlett 2004, 13, 2417-2420.
35. (d) Myers, M. C.; Witschi, M. A.; Larionova, N. V.; Franck, J. M.; Haynes, R. D.; Hara, T.; Grajkowski, A.; Apella, D. H. Org. Lett. 2003, 5, 2695-2698.
36. (a) Dominguez, B.; Hodnett, N. S.; Lloyd-Jones, G. C. Angew. Chem., Int. Ed. 2001, 40, 4289-4291.
37. (b) Gouin, S. G.; Gestin, J.-F.; Joly, K.; Loussouarn, A.; Reliquet, A.; Meslin, J. C.; Deniaud, D. Tetrahedron 2002, 58, 1131-1136.
38. (c) Hoffmann, R. W.; Klute, W.; Dress, R. K.; Wenzel, A. J. Chem. Soc., Perkin Trans. 2 1995, 1721-1726.
39. (d) Daly, A. M.; Gilheany, D. G. Tetrahedron: Asymmetry 2003, 14, 127-137.
40. (a) Pokorski, J. K.; Witschi, M. A.; Purnell, B. L.; Appella, D. H. J. Am. Chem. Soc. 2004, 126, 15067-15073.
41. (b) Pokorski, J. K.; Nam, J.-M.; Vega, R. A.; Mirkin, C. A.; Appella, D. H. Chem. Commun. 2005, 2055-2056.
42. Marshall, I. G.; Parsons, S. M. Trends Neurosci. 1987, 10, 174-177.
43. Du, B.; Daisy, J. J. PCT Int. Appl. 2003, WO 2003022799 A1; Chem. Abstr. 2003, 138, 254963.
44. Synthesized by ring opening of cyclopentene oxide with the corresponding secondary amine: González-Sabín, J.; Rebolledo F.; Gotor, V. Biotechnol. J. 2006, 1, 835-841.
45. González-Sabín, J.; Rebolledo, F.; Gotor, V. Chem. -Eur. J. 2004, 10, 5788-5794.
46. 1H NMR spectrum.
47. For some applications of aziridinium ions in synthesis, see: (a) Couturier, M.; Tucker, J. L.; Andresen, B. M.; DeVries, K. M.; Vanderplas, B. C.; Ito, F. Tetrahedron: Asymmetry 2003, 14, 3517-3523.
48. (b) Piotrowska, D. G.; Wróblewski, A. E. Tetrahedron 2003, 59, 8405-8410.
49. (c) Andrews, D. R.; Dahanukar, V. H.; Eckert, J. M.; Gala, D.; Lucas, B. S.; Schumacher, D. P.; Zavialov, I. A. Tetrahedron Lett. 2002, 43, 6121-6125.
50. (d) Chuang, T. H.; Sharpless, K. B. Org. Lett. 2000, 2, 3555-3557.
51. For some recent reviews, see: (a) Gotor-Fernández, V., Busto, E., Gotor, V. Adv. Synth. Catal. 2006, 348, 797-812.
52. (b) Van Rantwijk, F.; Sheldon, R. A. Tetrahedron 2004, 60, 501-519.
53. (c) Alfonso, I.; Gotor, V. Chem. Soc. Rev. 2004, 33, 201-209.
54. Chen, C. S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J. Am. Chem. Soc. 1982, 104, 7294-7299.
55. González-Sabín, J.; Rebolledo, F.; Gotor, V. Tetrahedron: Asymmetry 2004, 15, 481-488.
56. Kazlauskas, R. J.; Weissfloch, A. N. E.; Rappaport, A. T.; Cuccia, L. A. J. Org. Chem. 1991, 56, 2656-2665.
57. Allyl group was selectively removed employing a Pd(0) catalyst and mercaptobenzoic acid as allyl group scavenger: Lemaire-Audoire, S.; Savignac, M.; Genêt, J. P. Tetrahedron Lett. 1995, 36, 1267-1270.
58. (a) Boyd, E.; Coumbarides, G. S.; Eames, J.; Jones, R. V. H.; Stenson, R. A.; Suggate, M. J. Tetrahedron Lett. 2005, 46, 3473-3478.
59. (b) Bisai, A.; Bhanu Prasad, B. A.; Singh, V. K. Tetrahedron Lett. 2005, 46, 7935-7939.
60. (c) Holbach, M.; Zheng, X.; Burd, C.; Jones, C. W.; Weck, M. J. Org. Chem. 2006, 71, 2903-2906.